The 3 most recent market catalysts affecting $TBI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 85
TrueBlue shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.
This headline is a significant corporate catalyst for TrueBlue (TBI). The better-than-expected Q2 results demonstrate strong operational execution and potentially robust demand for…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 75
TrueBlue Sees Q3 Sales $461.000M-$481.000M vs $454.147M Est
TrueBlue (TBI) has announced Q3 sales guidance ranging from $461 million to $481 million, which is notably higher than the analyst consensus estimate of $454.147 million. This posi…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 95
TrueBlue Q2 Adj. EPS $0.06 Beats $(0.10) Estimate, Sales $443.001M Beat $417.840M Estimate
TrueBlue reported a substantial beat on both adjusted EPS and sales for Q2. The company posted adjusted earnings of $0.06 per share, significantly exceeding the analyst consensus e…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.